Binding properties of SA4503, a novel and selective σ1 receptor agonist

European Journal of Pharmacology

Volumn 306, Issue 1-3, 1996, Pages 271-279

  Matsuno, Kiyoshi ^a   Nakazawa, Minako ^a   Okamoto, Kazuyoshi ^a   Kawashima, Yoichi ^a   Mita, Shiro ^a  

^a SANTEN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

agonistic property; competitive inhibition; SA4503 (1 (3,4 dimethoxyphenethyl) 4 (3 phenylpropyl(piperazine dihydrochloride); 1 receptor subtype

Indexed keywords

1 (3,4 DIMETHOXYPHENETHYL) 4 (3 PHENYLPROPYL)PIPERAZINE; 1,3 BIS(2 METHYLPHENYL)GUANIDINE; ADENOSINE RECEPTOR; ALPHA ADRENERGIC RECEPTOR; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMINO ACID RECEPTOR; BETA ADRENERGIC RECEPTOR; DIHYDROALPRENOLOL; DOPAMINE RECEPTOR; GLUTAMIC ACID; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); HALOPERIDOL; HISTAMINE RECEPTOR; ION CHANNEL; MUSCARINIC RECEPTOR; N ALLYLNORMETAZOCINE; NEUROTRANSMITTER RECEPTOR; NEW DRUG; NICOTINIC RECEPTOR; OPIATE RECEPTOR; PENTAZOCINE; PENTOXYVERINE; PRAZOSIN; PRECLAMOL; RADIOLIGAND; RECEPTOR SUBTYPE; SEROTONIN RECEPTOR; SIGMA 1 OPIATE RECEPTOR; SIGMA 2 OPIATE RECEPTOR; SIGMA OPIATE RECEPTOR LIGAND; SIGMA OPIATE RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; BRAIN MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG INHIBITION; GUINEA PIG; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; SECOND MESSENGER;

EID: 0030582094     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00201-4     Document Type: Article

References (84)

1. 3H][2-D-penicillamine, 5-D-penicillamine]-enkephalin binding to δ opiate receptors in the rat brain and neuroblastoma-glioma hybrid cell line (NG108-115), Proc. Natl. Acad. Sci. USA 82, 2543.
2. 2-dopamine receptor, Eur. J. Pharmacol. 81, 493.
3. Beart, P.M., R.D. O'Shea and D.T. Manallack, 1989, Regulation of σ-receptors: high-and low-affinity agonist states, GTP shifts, and up-regulation by rimcazole and 1,3-di(2-tolyl)guanidine, J. Neurochem. 53, 779.
4. 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum, Life Sci. 35, 1885.
5. 3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus, J. Pharmacol. Exp. Ther. 267, 961.
6. 3H]N-methyl-carbamylcholine, a new radioligand specific for nicotinic acetylcholine receptors in brain, Eur. J. Pharmacol. 139, 323.
7. Bowen, W.D., B.N. Kirschner, A.M. Newman and K.C. Rice, 1988, σ Receptors negatively modulate agonist-stimulated phosphoinositide metabolism in rat brain, Eur. J. Pharmacol. 149, 399.
8. Bowen, W.D., S.B. Hellewell and K.A. McGarry, 1989, Evidence for a multisite model of the rat brain σ receptor, Eur. J. Pharmacol. 163, 309.
9. Brog, J.S. and M.C. Beinfeld, 1990, Inhibition of carbachol-induced inositol phosphate accumulation by phencyclidine, phencyclidine-like ligands and sigma agonists involves blockade of the muscarinic cholinergic receptor: a novel dioxadrol-preferring interaction, J. Pharmacol. Exp. Ther. 254, 952.
10. 2 receptors, Naunyn-Schmied. Arch. Pharmacol. 335, 64.
11. Candura, S.M., T. Coccini, L. Manzo and L.G. Costa, 1990, Interaction of σ-compounds with receptor-stimulated phosphoinositide metabolism in the rat brain, J. Neurochem, 55, 1741.
12. 1 binding sites in guinea pig brain, Eur. J. Pharmacol. 251, R1.
13. 3H]mepyramine binding of brain membranes, J. Neurochem. 32, 1653.
14. Connick, J.H., G. Hanlon, J. Roberts, L. France, P.K. Fox and C.D. Nicholson, 1992, Multiple σ binding sites in guinea-pig and rat brain membranes: G-protein interactions, Br. J. Pharmacol. 107, 726.
15. 3H](+)-pentazocine to σ recognition sites in guinea pig brain, Eur. J. Pharmacol. Mol. Pharmacol. 227, 371.
16. Dolphin, A.C., 1987, Nucleotide binding proteins in signal transduction and disease, Trends Neurosci. 10, 53.
17. 2-adrenoceptors in the vas deferens and central nervous system of the rat, Br. J. Pharmacol. 80, 155.
18. 3H]phorbol 12-myristate 13-acetate to mouse brain, Cancer Res. 40, 3635.
19. Eberlein, W.G., W. Engel, G. Mihm, K. Rudolf, B. Wetzel, M. Entzeroth, N. Mayer and H.N. Doods, 1989, Structure-activity relationships and pharmacological profile of selective tricyclic antimuscarinics, Trends Pharmacol. Sci. 10 (suppl.), 50.
20. Enna, S.J., J.F. Collins and S.H. Snyder, 1977, Stereospecificity and structure-activity requirements of GABA receptor binding in rat brain, Brain Res. 124, 185.
21. Gillan, M.G.C. and H.W. Kosterlitz, 1982, Spectrum of the μ-, δ-and κ-binding sites in homogenates of rat brain, Br. J. Pharmacol. 77, 461.
22. Gilman, A.G., 1986, Receptor-regulated G-proteins, Trends Neurosci. 9, 460.
23. Gilman, A.G., 1987, G proteins: transducers of receptor-generated signals, Ann. Rev. Biochem. 56, 615.
24. 3H]nitrendipine, Mol. Pharmacol. 25, 235.
25. 3 receptors, Digestion 45, 196.
26. Hellewell, S.B. and B.D. Bowen, 1990, A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain, Brain Res. 527, 244.
27. Hjorth, S., A. Carlsson, H. Wikström, P. Lindberg, D. Sanchez, U. Hacksell, L.-E. Arvidsson, U. Svensson and J.L.G. Nilsson, 1981, 3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors, Life Sci. 28, 1225.
28. Hjorth, S., D. Clark and A. Carlsson, 1985, Lack of functional evidence for the involvement of sigma opiate receptors in the actions of the 3-PPP enantiomers on central dopaminergic systems: discrepancies between in vitro and in vivo observations, Life Sci. 37, 673.
29. Hoffman, B.B., D. Mullikin-Kilpatrick and R.J. Lefkowitz, 1980, Heterogeneity of radioligand binding to α-adrenergic receptors, J. Biol. Chem. 255, 4645.
30. 3H]ketanserin, Eur. J. Pharmacol. 118, 13.
31. 3H]sulpiride binding sites in rat striatal membranes, Brain Res. 402, 331.
32. Itzhak, Y., 1989, Multiple affinity binding states of the σ receptor: effect of GTP-binding protein-modifying agents, Mol. Pharmacol. 36, 512.
33. Itzhak, Y., 1994, Multiple sigma binding sites in the brain, in: Sigma Receptors, ed. Y. Itzhak (Academic Press, San Diego, CA) p. 113.
34. Itzhak, Y. and M. Khouri, 1988, Regulation of the binding of σ-and phencyclidine (PCP)-receptor ligands in rat brain membranes by guanine nucleotides and ions, Neurosci. Lett. 85, 147.
35. Itzhak, Y. and I. Stein, 1991, Regulation of σ receptors and responsiveness to guanine nucleotides following repeated exposure of rats to haloperidol: further evidence for multiple σ binding sites, Brain Res. 566, 166.
36. Iyengar, S., V.M. Dilworth, S.J. Mick, P.C. Contreras, J.B. Manahan, T.S. Rao and P.L. Wood, 1990, Sigma receptors modulate both A9 and A10 dopaminergic neurons in the rat brain: functional interaction with NMDA receptors, Brain Res. 524, 322.
37. 2 receptors in rat brain, J. Pharmacol. Exp. Ther. 251, 888.
38. 3H]MK-801 binding: evidence for access to closed and open N-methyl-D-aspartate receptor channels, Mol. Pharmacol. 35, 387.
39. + channel of class III antiarrhythmic drug? Eur. J. Pharmacol. 241, 111.
40. 3H]acetylcholine release from rat hippocampal slices, Eur. J. Pharmacol. 200, 343.
41. Klein, M., T.B. Cooper and J.M. Musacchio, 1994, Effects of haloperidol and reduced haloperidol on binding to σ sites, Eur. J. Pharmacol. 254, 239.
42. 3H]U-69593 a highly selective ligand for the opioid κ receptor, Eur. J. Pharmacol. 109, 281.
43. 3H]-1-[1-(2-thienyl)cyclohexyl]piperidine, J. Pharmacol. Exp. Ther. 238, 739.
44. 3H]Butylbicycoorthobenzoate: new radioligand probe for the gamma-aminobutyric acid-regulated chloride ionophore, J. Neurochem. 45, 798.
45. Lefkowitz, R.J., M.G. Caron and G.L. Stiles, 1984, Mechanisms of membrane-receptor regulation, New Engl. J. Med. 310, 1570.
46. Lehmann, J., A.J. Hutchinson, S.E. McPherson, C. Mondadori, M. Schmutz, C.M. Sinton, C. Tsai, D.E. Murphy, D.J. Steel, M. Williams, D.L. Cheney and P.L. Wood, 1988, CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist, J. Pharmacol. Exp. Ther. 246, 65.
47. 2 binding in rat brain, Eur. J. Pharmacol. 259, 65.
48. 2 receptor binding sites: binding properties, brain distribution and functional role, Mol. Pharmacol. 21, 301.
49. 3H]kainic acid to receptor sites in rat brain, Mol. Pharmacol. 15, 492.
50. Lowry, O.H., N.J. Rosebrough, A.L. Farr and R.J. Randall, 1951, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193, 265.
51. 3 receptors in intact N1E-115 neuroblastoma cells, Eur. J. Pharmacol. 189, 223.
52. Matsuno, K., K. Matsunaga, T. Senda and S. Mita, 1993a, Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex, J. Pharmacol. Exp. Ther. 265, 851.
53. Matsuno, K., T. Senda and S. Mita, 1993b, Correlation between potentiation of neurogenic twitch contraction and benzomorphan σ receptor binding potency in the mouse vas deferens, Eur. J. Pharmacol. 231, 451.
54. Matsuno, K., T. Senda, K. Matsunaga and S. Mita, 1994, Ameliorating effects of σ receptor ligands on the impairment of passive avoidance tasks in mice: involvement in the central acetylcholinergic system, Eur. J. Pharmacol. 261, 43.
55. 1 receptor in (+)-N-allylnormetazocine-stimulated hippocampal cholinergic functions in rats, Brain Res. 690, 200.
56. 1 receptor agonistic properties, Behav. Brain Res. (in press).
57. Maurice, T., M. Hiramatsu, J. Itoh, T. Kameyama, T. Hasegawa and T. Nabeshima, 1994a, Behavioral evidence for a modulating role of σ ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia, Brain Res. 647, 44.
58. Maurice, T., M. Hiramatsu, T. Kameyama, T. Hasegawa and T. Nabeshima, 1994b, Behavioral evidence for a modulating role of σ ligands in memory processes. II. Reversion of carbon monoxide-induced amnesia, Brain Res., 647, 57.
59. 1 receptors, Behav. Brain Res. (in press).
60. 3H]SKF-10,047 to σ sites, Eur. J. Pharmacol. 180, 361.
61. 3H]noradrenaline release in the rat hippocampus: G-protein dependency, Naunyn-Schmied. Arch. Pharmacol. 346, 32.
62. 3H]α-amino-5-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and a filtration assay, Neurochem. Res. 12, 775.
63. Quirion, R., W.D. Bowen, Y. Itzhak, J.L. Junien, J.M. Musacchio, R.B. Rothman, T.-P. Su, S.W. Tam and D.P. Taylor, 1992, A proposal for the classification of sigma binding sites, Trends Pharmacol. Sci. 13, 85.
64. Riva, M.A. and I. Creese, 1989, Reevaluation of the regulation of β-adrenergic receptor binding by desipramine treatment, Mol. Pharmacol. 36, 211.
65. B receptors, Brain Res. Bull. 21, 439.
66. Seager, M.J., B. Marqueze and F. Couraud, 1987, Solubilization of the apamin receptor associated with a calcium-activated potassium channel from rat brain, J. Neurosci. 7, 565.
67. 3H]forskolin to rat brain memebranes, Proc. Natl. Acad. Sci. USA 81, 5081.
68. Senda, T., K. Matsuno and S. Mita, 1995, Differences in the high affinity sites of σ receptors between guinea pig and rat brain, Neurosci. Res. Commun. 17, 97.
69. Sibley, D.R., A. De Lean and I. Creese, 1982, Anterior pituitary dopamine receptors, J. Biol. Chem. 257, 6351.
70. Siniscalchi, A., P. Cristofori and E. Veratti, 1987, Influence of N-allylnormetazocine on acetylcholine release from brain slices: Involvement of muscarinic receptors, Naunyn-Schmied. Arch. Pharmacol. 336, 425.
71. 3H]SKF10,047 binding in rat and mouse brain: further evidence for phencyclidine/'sigma opiate' receptor commonality, J. Pharmacol. Exp. Ther. 237, 681.
72. 3H]-L-glutamate to cerebeller membranes: evidence for recognition site heterogeneity, Brain Res. 249, 353.
73. Snell, L.D., R.S. Morter and K.M. Johnson, 1988, Structural requirements for activation of the glycine receptor that modulates the N-methyl-D-aspartate operated ion channel, Eur. J. Pharmacol. 156, 105.
74. 2, in: NMDA Receptor Related Agents: Biochemistry, Pharmacology and Behavior, ed. T. Kameyama, T. Nabeshima and E.F. Domino (NPP Books, Ann Arbor) p. 227.
75. Sweetnam, P.M. and J.F. Tallman, 1986, Regional difference in brain benzodiazepine receptor carbohydrates, Mol. Pharmacol. 29, 299.
76. 1-adrenoceptors, Mol. Pharmacol. 20, 295.
77. 3H]TCP: a new tool with high affinity for the PCP receptor in rat brain, Brain Res. 280, 194.
78. Vilner, B.J. and W.D. Bowen, 1992, Characterization of sigma-like binding sites of NB41A3, S-20Y and N1E-115 neuroblastomas, C6 glioma and NG108-15 neuroblastoma-glioma hybrid cells: further evidence for sigma-2 receptors, in: Multiple Sigma and PCP Receptor Ligands: Mechanisms for Neuromodulation and Neuroprotection?, ed. J.-M. Kamenka and E.F. Domino (NPP Books, Ann Arbor) p. 341.
79. Wagner, J.A., A.M. Snowman, A. Biswas, B.M. Olivera and S.H. Snyder, 1988, ω-Conotoxin GVIA binding to a high-affinity receptor in brain: characterization, calcium sensitivity, and solubilization, J. Neurosci. 8, 3354.
80. 2 receptors in motor function, Eur. J. Pharmacol. 231, 61.
81. 2 muscarinic subtypes, Life Sci. 32, 3001.
82. Worley, P.F., J.M. Baraban, S. Supattapone, V.S. Wilson and S.H. Snyder, 1987, Characterization of inositol trisphosphate receptor binding in brain, J. Biol. Chem. 262, 12132.
83. Young, A.B. and S.H. Snyder, 1974, Strychnine binding in rat spinal cord membranes associated with the synaptic glycine receptor: cooperativity of glycine interactions, Mol. Pharmacol. 10, 790.
84. Zhang, J., L.A. Chiodo, J.G. Wettstein, J.-L. Junien and A.S. Freeman, 1992, Acute effects of sigma ligands on the electrophysiological activity of rat nigrostriatal and mesoaccumbal dopaminergic neurons, Synapse 11, 267.